Jacob M. Miller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jacob M. Miller has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Eric M. Rubenstein
Ball State University
2 shared publications - Kelsey A. Woodruff
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
2 shared publications - Samantha M. Turk
Ball State University
2 shared publications Avery M. Runnebohm
Department of Biology, Ball State University, Muncie, Indiana, USA
1 shared publicationBryce W. Buchanan
Department of Biology, Ball State University, Muncie, Indiana, USA
1 shared publication- Cade J. Orchard
Department of Biology, Ball State University, Muncie, Indiana, USA
1 shared publication
Latest Publications
- Open Access
Dfm1 promotes Ste24-dependent translocon quality control
Proteins stalled during endoplasmic reticulum translocation clog Sec61 channels and require translocon quality control (TQC) mechanisms for clearance. Genetic screens implicated the derlin Dfm1 in TQC; however, its mechanistic role remained unclear. Using engineered and disease-relevant translocon-clogging substrates in Saccharomyces cerevisiae, we show Dfm1 functions in the Ste24-dependent branch of TQC, but not Hrd1- or Ltn1-dependent pathways. Loss of DFM1 increased accumulation and toxicity of translocon-clogging proteins. Increased dosage of wild type or catalytically inactive Hrd1 or Ste24 rescued toxicity, supporting a non-enzymatic buffering function for these factors in TQC. These findings identify Dfm1 as a key TQC factor whose critical role in clearing clogged translocons can be suppressed in multiple ways. Our results suggest enhancing TQC may protect cells from proteotoxic stress caused by disease-relevant translocon-clogging substrates, with potential implications for pancreatic β-cell dysfunction in diabetes.
Open AccessDfm1 promotes Ste24-dependent translocon quality control
Proteins stalled during endoplasmic reticulum translocation clog Sec61 channels and require translocon quality control (TQC) mechanisms for clearance. Genetic screens implicated the derlin Dfm1 in TQC; however, its mechanistic role remained unclear. Using engineered and disease-relevant translocon-clogging substrates in Saccharomyces cerevisiae, we show Dfm1 functions in the Ste24-dependent branch of TQC, but not Hrd1- or Ltn1-dependent pathways. Loss of DFM1 increased accumulation and toxicity of translocon-clogging proteins. Increased dosage of wild type or catalytically inactive Hrd1 or Ste24 rescued toxicity, supporting a non-enzymatic buffering function for these factors in TQC. These findings identify Dfm1 as a key TQC factor whose critical role in clearing clogged translocons can be suppressed in multiple ways. Our results suggest enhancing TQC may protect cells from proteotoxic stress caused by disease-relevant translocon-clogging substrates, with potential implications for pancreatic β-cell dysfunction in diabetes.
- Open Access
- 16 June 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (8) , 104939
Lipid biosynthesis perturbation impairs endoplasmic reticulum–associated degradation
- 16 June 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (8) , 104939
Open AccessLipid biosynthesis perturbation impairs endoplasmic reticulum–associated degradation